Company news
Shanghai Serum Bio-Technology Co., Ltd. news in 2026
Shanghai Serum Bio-Technology Co., Ltd.'s news releases, calls and decks from 2026, newest first.
(688163)"SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD."Announcement on Attending the Q3 2026 Collective Performance Briefing of Listed Companies in Shanghai Jurisdiction
November 2, 2026
(688163)"SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD."Report for Q3 2026
October 27, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
September 28, 2026
Announcement on Voluntary Disclosure of Receipt of the Certificate of GMP Compliance from the Philippines
September 24, 2026
Announcement on Departure of a Director, Senior Management Member and Core Technical Personnel, By-election of a Director and Adjustment of Core Technical Personnel
September 11, 2026
Announcement on Implementation of Dividend Distribution for the First Half of 2026
September 8, 2026
Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Biological Products and CXO Industry
September 3, 2026
Announcement on the Profit Distribution Plan for the First Half of 2026
August 21, 2026
Announcement on Change of Secretary of the Board of Directors
June 8, 2026
Announcement on Implementation of Dividend Distribution for 2025
May 22, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 15, 2026
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of Anti-bee Venom Serum
May 7, 2026
Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
April 28, 2026
Announcement on Renewing Engagement of Audit Institution for 2026
April 24, 2026
Announcement on Using Self-owned Funds to Pay Personnel Expenses for Investment Projects Financed by Raised Funds and Replacing with Equal Raised Funds
March 20, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 26, 2026